Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Role of diacylglycerol acyltransferase 2 (DGAT2) in group 2 innate lymphoid cell (ILC2) function
FY 2018-19
Summary
The immune system is complex and multi-layered but can be divided into two major types of host responses: innate and adaptive. The innate response is rapid but non-specific; for example, it quickly and non-specifically clears bacteria from wounds. The adaptive response develops more slowly, but mounts a much stronger, pathogen-specific response that develops into immunological memory. Group 2 innate lymphoid cells (ILC2) serve as messengers between these two major arms of the immune system, responding to innate signals and activating the adaptive response.
ILC2 are an essential part of type 2 immunity, which evolved as a tissue restorative response to infections at mucosal barrier sites, such as the lung and the gut. However, when this response is dysregulated, it can lead to immunopathologies such as allergies and asthma. Thus, studying its regulation is critical to discover novel therapies to treat these diseases, and ILC2 are promising therapeutic targets. Nevertheless, many mechanisms governing their regulation remain largely unknown.
Unpublished research in our laboratory has revealed that activation of ILC2 leads to a strong induction of an enzyme involved lipid metabolism, diacylglycerol O-acyltransferase 2 (Dgat2). This enzyme catalyzes the formation of fat within a cell, which is then stored in lipid droplets as an energy reservoir, preventing toxic accumulation of free fatty acids. Therefore, we hypothesize that higher levels of Dgat2 allow activated ILC2 to take up high levels of fatty acids for storage without any toxic effects. Elucidating the role of Dgat2 and lipid metabolism in ILC2 will contribute to understanding their poorly characterized metabolic requirements and will lead to novel drug targets to alter ILC2 functions in type 2 immunopathologies.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
406417
Name
Hewgill Shannon A
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Role of diacylglycerol acyltransferase 2 (DGAT2) in group 2 innate lymphoid cell (ILC2) function
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Dgat2; Ilc2; Immunometabolism; Lipid Droplets; Lipid Metabolism; Type 2 Immunity
Abstract
The immune system is complex and multi-layered but can be divided into two major types of host responses: innate and adaptive. The innate response is rapid but non-specific; for example, it quickly and non-specifically clears bacteria from wounds. The adaptive response develops more slowly, but mounts a much stronger, pathogen-specific response that develops into immunological memory. Group 2 innate lymphoid cells (ILC2) serve as messengers between these two major arms of the immune system, responding to innate signals and activating the adaptive response.
ILC2 are an essential part of type 2 immunity, which evolved as a tissue restorative response to infections at mucosal barrier sites, such as the lung and the gut. However, when this response is dysregulated, it can lead to immunopathologies such as allergies and asthma. Thus, studying its regulation is critical to discover novel therapies to treat these diseases, and ILC2 are promising therapeutic targets. Nevertheless, many mechanisms governing their regulation remain largely unknown.
Unpublished research in our laboratory has revealed that activation of ILC2 leads to a strong induction of an enzyme involved lipid metabolism, diacylglycerol O-acyltransferase 2 (Dgat2). This enzyme catalyzes the formation of fat within a cell, which is then stored in lipid droplets as an energy reservoir, preventing toxic accumulation of free fatty acids. Therefore, we hypothesize that higher levels of Dgat2 allow activated ILC2 to take up high levels of fatty acids for storage without any toxic effects. Elucidating the role of Dgat2 and lipid metabolism in ILC2 will contribute to understanding their poorly characterized metabolic requirements and will lead to novel drug targets to alter ILC2 functions in type 2 immunopathologies.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hewgill, Shannon A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~